Articles

Articles 42 registres trobats  inicianterior33 - 42  anar al registre: La cerca s'ha fet en 0.00 segons. 
33.
10 p, 365.3 KB Hospital and 4-year mortality predictors in patients with acute pulmonary edema with and without coronary artery disease / Figueras Bellot, Jaume (Hospital Universitari Vall d'Hebron) ; Bañeras, Jordi (Hospital Universitari Vall d'Hebron) ; Peña-Gil, Carlos (Complexo Hospitalario Universitario de Vigo) ; Barrabés, José A (Hospital Universitari Vall d'Hebron) ; Rodríguez Palomares, José Fernando (Hospital Universitari Vall d'Hebron) ; García-Dorado, David (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Long-term prognosis of acute pulmonary edema () remains ill defined. We evaluated demographic, echocardiographic, and angiographic data of 806 consecutive patients with with () and without coronary artery disease (non-) admitted from 2000 to 2010. [...]
2016 - 10.1161/JAHA.115.002581
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 5, issue 2 (Feb. 2016)  
34.
13 p, 508.4 KB Meeting report from the 2nd International Symposium on New Frontiers in Cardiovascular Research. Protecting the cardiovascular system from ischemia : between bench and bedside / Cabrera-Fuentes, H. A (Escuela de Ingeniería y Ciencias, Centro de Biotecnología-FEMSA, Tecnológico de Monterrey) ; Alba-Alba, Corina (Institute of Genetics, Univeristy of the Sea. Puerto Escondido Campus, Oaxaca Oaxacan System of State Universities (SUNEO)) ; Aragones, Julian (Instituto de Investigación Hospital Universitario de la Princesa) ; Bernhagen, Jürgen (Institute of Biochemistry and Molecular Cell Biology, RWTH Aachen University) ; Boisvert, William A. (Center for Cardiovascular Research, John A. Burns School of Medicine, University of Hawaii) ; Bøtker, Hans Erik (Aarhus University Hospital (Aarhus, Dinamarca)) ; Cesarman-Maus, Gabriela (Department of Hematology, Instituto Nacional de Cancerología, Mexico City, Mexico) ; Fleming, Ingrid (Institute for Vascular Signalling, Centre for Molecular Medicine, Goethe-University, Frankfurt, Germany) ; García-Dorado, David (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Lecour, Sandrine (Hatter Institute and MRC Inter-University Cape Heart Unit, Faculty of Health Sciences, University of Cape Town) ; Liehn, Elisa (Institute for Molecular Cardiovascular Research, RWTH University Hospital Aachen) ; Marber, Michael S. (King's College London) ; Marina, Nephtali (Department of Clinical Pharmacology, University College London) ; Mayr, Manuel (King's College London. The James Black Centre) ; Perez-Mendez, Oscar (Department of Molecular Biology, National Institute of Cardiology, Mexico City) ; Miura, Tetsuji (Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine) ; Ruiz-Meana, Marisol (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Salinas-Estefanon, Eduardo M. (Laboratorio de Biofísica Cardiaca, Instituto de Fisiología, Universidad Autónoma de Puebla, Puebla, Mexico) ; Ong, Sang-Bing (National Heart Research Institute Singapore, National Heart Centre Singapore) ; Schnittler, Hans J. (Institute of Anatomy and Vascular Biology, Westfalian-Wilhelms-University, Münster) ; Sanchez-Vega, Jose T. (Universidad Nacional Autónoma de México. Departamento de Microbiología y Parasitología) ; Sumoza-Toledo, Adriana (Laboratorio Multidisciplinario de Ciencias Biomédicas, Instituto de Investigaciones Medico-Biológicas, Universidad Veracruzana campus Veracruz) ; Vogel, Carl-Wilhelm (Department of Pathology, John A. Burns School of Medicine, University of Hawaii) ; Yarullina, Dina (Department of Microbiology, Kazan Federal University, Kazan, Russian Federation) ; Yellon, Derek M. (The National Institute of Health Research University College London Hospitals Biomedical Research Centre) ; Preissner, Klaus T. (Institute of Biochemistry, Medical School, Justus-Liebig University, Giessen, Germany) ; Hausenloy, Derek J. (The National Institute of Health Research University College London Hospitals Biomedical Research Centre) ; Universitat Autònoma de Barcelona
Recent advances in basic cardiovascular research as well as their translation into the clinical situation were the focus at the last "New Frontiers in Cardiovascular Research meeting". Major topics included the characterization of new targets and procedures in cardioprotection, deciphering new players and inflammatory mechanisms in ischemic heart disease as well as uncovering microRNAs and other biomarkers as versatile and possibly causal factors in cardiovascular pathogenesis. [...]
2015 - 10.1007/s00395-015-0527-0
Basic Research in Cardiology, Vol. 111 (december 2015)  
35.
10 p, 1.1 MB Clinical benefit of adenosine as an adjunct to reperfusion in ST-elevation myocardial infarction patients : An updated meta-analysis of randomized controlled trials / Bulluck, Heerajnarain (The Heart Hospital) ; Sirker, Alex (The Heart Hospital) ; Loke, Yoon K. (University of East Anglia) ; García-Dorado, David (Hospital Universitari Vall d'Hebron) ; Hausenloy, Derek J. (National Heart Research Institute Singapore) ; Universitat Autònoma de Barcelona
Adenosine administered as an adjunct to reperfusion can reduce coronary no-reflow and limit myocardial infarct (MI) size in ST-segment elevation myocardial infarction (STEMI) patients. Whether adjunctive adenosine therapy can improve clinical outcomes in reperfused STEMI patients is not clear and is investigated in this meta-analysis of 13 randomized controlled trials (RCTs). [...]
2016 - 10.1016/j.ijcard.2015.09.005
International Journal of Cardiology, Vol. 202 (january 2016) , p. 228-237  
36.
10 p, 447.5 KB Genetic association study of coronary collateral circulation in patients with coronary artery disease using 22 single nucleotide polymorphisms corresponding to 10 genes involved in postischemic neovascularization / Duran, Joan (Universitat de Barcelona. Departament de Patologia i Terapèutica Experimental) ; Olavarría, Pilar Sánchez (Departamento de Estadística, Facultad de Ciencias, Universidad de Valparaíso) ; Mola, Marina (Parc de Recerca Biomèdica de Barcelona (PRBB)) ; Götzens, Víctor (Universitat de Barcelona. Departament de Patologia i Terapèutica Experimental) ; Carballo, Julio (Centre Cardiovascular Sant Jordi) ; Pelegrina, Eva Martín (Centre Cardiovascular Sant Jordi) ; Petit, Màrius (Centre Cardiovascular Sant Jordi) ; Abdul-Jawad Altisent, Omar (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya)) ; Otaegui, Imanol (Hospital Universitari Vall d'Hebron) ; García del Blanco, Bruno (Hospital Universitari Vall d'Hebron) ; García-Dorado, David (Hospital Universitari Vall d'Hebron) ; Reig Vilallonga, Josep (Universitat Autònoma de Barcelona. Departament de Ciències Morfològiques) ; Cordero, Alex (Institut d'Investigació Biomèdica de Bellvitge) ; de Anta, Josep Maria (Universitat de Barcelona. Departament de Patologia i Terapèutica Experimental)
Collateral growth in patients with coronary artery disease (CAD) is highly heterogeneous. Although multiple factors are thought to play a role in collateral development, the contribution of genetic factors to coronary collateral circulation (CCC) is largely unknown. [...]
2015 - 10.1186/s12872-015-0027-z
BMC Cardiovascular disorders, Vol. 15 (may 2015)  
37.
15 p, 2.3 MB Defective sarcoplasmic reticulum-mitochondria calcium exchange in aged mouse myocardium / Fernández Sanz, Celia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Ruiz-Meana, M. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Miro-Casas, E. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Nuñez, E. (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ; Castellano, J. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Loureiro, M. (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ; Barba, Ignasi (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Poncelas, M. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Rodriguez-Sinovas, A. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Vázquez, Jesús (Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares) ; García-Dorado, David (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Mitochondrial alterations are critically involved in increased vulnerability to disease during aging. We investigated the contribution of mitochondria-sarcoplasmic reticulum (SR) communication in cardiomyocyte functional alterations during aging. [...]
2014 - 10.1038/cddis.2014.526
Cell death and disease, Vol. 5 (december 2014) , p. e1573  
38.
13 p, 340.4 KB ESC working group cellular biology of the heart : position paper: improving the preclinical assessment of novel cardioprotective therapies / Lecour, Sandrine (Hatter Institute for Cardiovascular Research (Àfrica)) ; Bøtker, Hans Erik (Aarhus University Hospital (Aarhus, Dinamarca)) ; Condorelli, Gianluigi (Instituto Clinico Humanitas (Milano, Itàlia)) ; Davidson, Sean M. (Hatter Institute for Cardiovascular Research (Londres, Regne Unit)) ; García-Dorado, David (Universitat Autònoma de Barcelona) ; Engel, Felix B. (Friedrich-Alexander-Universität Erlangen-Nürnberg) ; Ferdinandy, Péter (Semmelweis Egyetem. Department of Pharmacology and Pharmacotherapy) ; Heusch, Gerd (Universitätsklinikum Essen) ; Madonna, Rosalinda (Università degli Studi "G. d'Annunzio" Chieti) ; Ovize, Michel (Université Claude Bernard Lyon 1) ; Ruiz Meana, Marisol (Hospital Universitari Vall d'Hebron) ; Schulz, Rainer (Justus Liebig-Universität Gießen) ; Sluijter, Joost P. G. (Universitair Medisch Centrum Utrecht) ; Van Laake, Linda W. (Universitair Medisch Centrum Utrecht) ; Yellon, Derek M. (Hatter Institute for Cardiovascular Research (Londres, Regne Unit)) ; Hausenloy, Derek J. (Hatter Institute for Cardiovascular Research (Londres, Regne Unit))
Ischaemic heart disease (IHD) remains the leading cause of death and disability worldwide. As a result, novel therapies are still needed to protect the heart from the detrimental effects of acute ischaemia-reperfusion injury, in order to improve clinical outcomes in IHD patients. [...]
2014 - 10.1093/cvr/cvu225
Cardiovascular research, Vol. 104, issue 3 (Dec. 2014) , p. 399-411  
39.
21 p, 3.3 MB Single Intracoronary Injection of Encapsulated Antagomir-92a Promotes Angiogenesis and Prevents Adverse Infarct Remodeling / Bellera Gotarda, Neus (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Barba, Ignasi (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Rodriguez-Sinovas, Antonio (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Ferret, Eulalia (I+D Pierre-Fabre Ibérica S.A) ; Asín, Miguel Angel (I+D Pierre-Fabre Ibérica S.A) ; Gonzalez-Alujas, MªTeresa (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Pérez-Rodón, Jordi (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Esteves, Marielle (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Fonseca, Carla (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Toran, Nuria (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; García del Blanco, Bruno (Hospital Universitari Vall d'Hebron) ; Pérez, Amadeo (I+D Pierre-Fabre Ibérica S.A) ; García-Dorado, David (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Small and large preclinical animal models have shown that antagomir-92a-based therapy reduces early postischemic loss of function, but its effect on postinfarction remodeling is not known. In addition, the reported remote miR-92a inhibition in noncardiac organs prevents the translation of nonvectorized miR-targeted therapy to the clinical setting. [...]
2014 - 10.1161/JAHA.114.000946
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 3 (september 2014)  
40.
13 p, 1.4 MB Activation of cGMP/Protein Kinase G Pathway in Postconditioned Myocardium Depends on Reduced Oxidative Stress and Preserved Endothelial Nitric Oxide Synthase Coupling / Inserte, Javier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Hernando, Víctor (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Vilardosa, Úrsula (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Abad, Elena (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Poncelas-Nozal, Marcos (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; García-Dorado, David (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
The cGMP/protein kinase G (PKG) pathway is involved in the cardioprotective effects of postconditioning (PoCo). Although PKG signaling in PoCo has been proposed to depend on the activation of the phosphatidylinositol 3-kinase (PI3K)/Akt cascade, recent data bring into question a causal role of reperfusion injury signaling kinase (RISK) in PoCo protection. [...]
2013 - 10.1161/JAHA.112.005975
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 2 (february 2013)  
41.
12 p, 565.3 KB Impact of Triple Therapy in Elderly Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention / Sambola, Antonia (Hospital Universitari Vall d'Hebron) ; Mutuberria Urdániz, María (Hospital Universitari Vall d'Hebron) ; García del Blanco, Bruno (Hospital Universitari Vall d'Hebron) ; Alonso, Albert (Hospital Universitari Vall d'Hebron) ; Barrabés, José A (Hospital Universitari Vall d'Hebron) ; Bueno, Héctor (Hospital General Universitario Gregorio Marañón) ; Alfonso, Fernando (Hospital Clínico San Carlos (Madrid)) ; Cequier, Ángel (Hospital Universitari de Bellvitge) ; Zueco, Javier (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ; Rodríguez Leor, Oriol (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Tornos Mas, Pilar (Hospital Universitari Vall d'Hebron) ; García-Dorado, David (Hospital Universitari Vall d'Hebron)
Background and purpose: Selecting an ideal antithrombotic therapy for elderly patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) can be challenging since they have a higher thromboembolic and bleeding risk than younger patients. [...]
2016 - 10.1371/journal.pone.0147245
PloS one, Vol. 11 Núm. 1 (January 2016)  
42.
7 p, 318.6 KB Prothrombotic profile in patients with vasospastic or non vasospastic angina and non significant coronary stenosis / Figueras Bellot, Jaume (Hospital Universitari Vall d'Hebron) ; Monasterio Aspiri, Jasone (Hospital Universitari Vall d'Hebron) ; Domingo Ribas, Enric (Hospital Universitari Vall d'Hebron) ; Meneses Londoño, Beatriz E. (Hospital Universitari Vall d'Hebron) ; Nieto Santa, Elsa (Hospital Universitari Vall d'Hebron) ; Cortadellas Ángel, Josefa (Hospital Universitari Vall d'Hebron) ; García Dorado, D.. (Hospital Universitari Vall d'Hebron)
Background: Patients with vasospastic (VA) or non vasospastic angina (NVA) without significant coronary stenosis have a reduced risk of infarction but is unclear whether or not this may be attributable to a lack of prothrombotic profile - similar to that present in patients with stable coronary artery disease (CAD). [...]
2011 - 10.1186/1477-9560-9-10
Thrombosis journal, Vol. 9, Núm. 10 (May 2011), p. 1-7  

Articles : 42 registres trobats   inicianterior33 - 42  anar al registre:
Vegeu també: autors amb noms similars
5 Garcia-Dorado, D.
44 Garcia-Dorado, David
5 Garcia-Dorado, David,
44 García-Dorado, David
5 García-Dorado, David,
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.